Literature DB >> 33514720

Risks of poor asthma outcome in 14,405 children and young people in London.

Mark L Levy1.   

Abstract

This is a 12-month retrospective data analysis (2018/19) of asthma risk factors in 350 North West London general practices. Fourteen thousand four hundred and five of the 482,029 (40% female) children and young people (CYP) had diagnosed asthma. Exacerbations are as follows: (i) 749 (5%) CYP had 797 hospital admissions; 32 (<1%) had 2-6; (ii) 910 (6%) had 1168 recorded asthma attacks; 170 (1%) had 2-12; (iii) 1485 (10%) had 2123 oral corticosteroid courses; 408 (3%) had 2-11. Excess short-acting bronchodilators were prescribed in over half of the CYP. Of the 10,077 (70%) CYP prescribed inhaled corticosteroid preventers, 7279 (72%) were issued with <4 ICS inhaler prescriptions during the year; these CYP accounted for 11% of the admission spells. In all, 30% of CYP had poor symptom control. At least 10% of the CYP having had recent attacks are at risk and dashboards such as those available in North West London could easily facilitate recognition of risk and optimisation of care.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33514720      PMCID: PMC7846552          DOI: 10.1038/s41533-020-00215-7

Source DB:  PubMed          Journal:  NPJ Prim Care Respir Med        ISSN: 2055-1010            Impact factor:   2.871


  25 in total

1.  Changing prevalence of current asthma and inhaled corticosteroid treatment in the UK: population-based cohort 2006-2016.

Authors:  Chloe I Bloom; Sejal Saglani; Johanna Feary; Debbie Jarvis; Jennifer K Quint
Journal:  Eur Respir J       Date:  2019-04-04       Impact factor: 16.671

Review 2.  Inhaled corticosteroids: impact on asthma morbidity and mortality.

Authors:  S Suissa; P Ernst
Journal:  J Allergy Clin Immunol       Date:  2001-06       Impact factor: 10.793

3.  Low-dose inhaled corticosteroids and the prevention of death from asthma.

Authors:  S Suissa; P Ernst; S Benayoun; M Baltzan; B Cai
Journal:  N Engl J Med       Date:  2000-08-03       Impact factor: 91.245

4.  Development of the asthma control test: a survey for assessing asthma control.

Authors:  Robert A Nathan; Christine A Sorkness; Mark Kosinski; Michael Schatz; James T Li; Philip Marcus; John J Murray; Trudy B Pendergraft
Journal:  J Allergy Clin Immunol       Date:  2004-01       Impact factor: 10.793

5.  Short-acting β-agonist use and its ability to predict future asthma-related outcomes.

Authors:  Richard H Stanford; Manan B Shah; Anna O D'Souza; Amol D Dhamane; Michael Schatz
Journal:  Ann Allergy Asthma Immunol       Date:  2012-10-01       Impact factor: 6.347

6.  Asthma-Related Health Outcomes Associated with Short-Acting β2-Agonist Inhaler Use: An Observational UK Study as Part of the SABINA Global Program.

Authors:  Chloe I Bloom; Claudia Cabrera; Sofie Arnetorp; Karen Coulton; Cassandra Nan; Ralf J P van der Valk; Jennifer K Quint
Journal:  Adv Ther       Date:  2020-07-27       Impact factor: 3.845

7.  Asthma prescribing, ethnicity and risk of hospital admission: an analysis of 35,864 linked primary and secondary care records in East London.

Authors:  Sally A Hull; Shauna McKibben; Kate Homer; Stephanie Jc Taylor; Katy Pike; Chris Griffiths
Journal:  NPJ Prim Care Respir Med       Date:  2016-08-18       Impact factor: 2.871

8.  Management of children and young people (CYP) with asthma: a clinical audit report.

Authors:  Mark L Levy; Angela Ward; Sara Nelson
Journal:  NPJ Prim Care Respir Med       Date:  2018-05-21       Impact factor: 2.871

9.  A review of asthma care in 50 general practices in Bedfordshire, United Kingdom.

Authors:  Mark L Levy; Fiona Garnett; Adedayo Kuku; Inna Pertsovskaya; Eddie McKnight; John Haughney
Journal:  NPJ Prim Care Respir Med       Date:  2018-07-26       Impact factor: 2.871

10.  How an electronic health record became a real-world research resource: comparison between London's Whole Systems Integrated Care database and the Clinical Practice Research Datalink.

Authors:  Alex Bottle; Carole Cohen; Amanda Lucas; Kavitha Saravanakumar; Zia Ul-Haq; Wayne Smith; Azeem Majeed; Paul Aylin
Journal:  BMC Med Inform Decis Mak       Date:  2020-04-20       Impact factor: 2.796

View more
  1 in total

1.  The Children's Anti-inflammatory Reliever (CARE) study: a protocol for a randomised controlled trial of budesonide-formoterol as sole reliever therapy in children with mild asthma.

Authors:  Lee Hatter; Pepa Bruce; Mark Holliday; Augustus J Anderson; Irene Braithwaite; Andrew Corin; Allie Eathorne; Arthur Grimes; Matire Harwood; Thomas Hills; Ciléin Kearns; Kyley Kerse; John Martindale; Barney Montgomery; Lynn Riggs; Davitt Sheahan; Nick Shortt; Katja Zazulia; Mark Weatherall; David McNamara; Catherine A Byrnes; Andrew Bush; Stuart R Dalziel; Richard Beasley
Journal:  ERJ Open Res       Date:  2021-10-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.